Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
210 participants
INTERVENTIONAL
2003-06-30
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women
NCT01401946
Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause
NCT00925639
Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women
NCT06759350
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
NCT01723917
Womens Study to Alleviate Vasomotor Symptoms
NCT04587154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isoflavone supplement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
38 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nichimo - Tokyo, Japan
UNKNOWN
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hope Ricciotti
Associate Professor of Obstetrics, Gynecology and Reproductive Biology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hope Ricciotti, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
George Blackburn, MD, PhD
Role: STUDY_CHAIR
Beth Israel Deaconess Medical Center
Lalita Khaodhiar, MD
Role: STUDY_DIRECTOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2002P000037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.